Select Page

CATALENT HAS ACQUIRED MASTHERCELL

Enhancing capabilities in cell and gene therapy development and manufacturing to create a comprehensive solution for advanced biotherapeutics
Catalent is the #1 partner in helping pharmaceutical, biotech and consumer health innovators develop, deliver and supply superior products that improve people’s lives.

CATALENT ACQUIRES PREMIER EUROPEAN SITE FROM
BRISTOL-MYERS SQUIBB

Enhancing Biologics and Oral dose capabilities and capacity for product launch and commercial packaging

Your Expert Partner in Gene Therapy

Industry-leading expertise in adeno-associated viral vector (AAV) development and manufacturing

Introducing OneBioSM Suite

Accelerating timelines through integrated biologics development, manufacturing & supply

CATALENT HAS ACQUIRED MASTHERCELL

Enhancing capabilities in cell and gene therapy development and manufacturing to create a comprehensive solution for advanced biotherapeutics.

Catalent is the #1 partner in helping pharmaceutical, biotech and consumer health innovators develop, deliver and supply superior products that improve people’s lives.

CATALENT ACQUIRES PREMIER EUROPEAN SITE FROM BRISTOL-MYERS SQUIBB

Enhancing Biologics and Oral dose capabilities and capacity for product launch and commercial packaging

YOUR EXPERT PARTNER IN GENE THERAPY

Industry-leading expertise in adeno-associated viral vector (AAV) development and manufacturing

INTRODUCING ONEBIOSM SUITE

Accelerating timelines through integrated biologics development, manufacturing & supply.

How can we work together

baiduxml